As a generally held principle, mere investment or ownership interest in a company does not expose the investor to liability for acts undertaken by the company. However, that principle is being called into question in the context of private equity firms investing in healthcare companies. In two recent cases, healthcare companies along with their sole or majority private equity firm owners settled False Claims Act (“FCA”) cases. These cases illustrate the risk that private equity investors in the healthcare space may face under the FCA, particularly to the extent that they actively manage their portfolio companies.
Trending
- OpenEvidence Raises $250 Million to Build Medical Superintelligence for Doctors (Business Wire)
- A Health Economic Evaluation of Digital Digestive Care Management (AJMC)
- Cedars-Sinai Secures Grant to Expand IBD Program Internationally (Cedars Sinai)
- GI leaders name the biggest disruptors of 2026 (Becker’s GI & Endoscopy)
- Private Equity’s Healthcare Boom Is Getting More Crowded (MedCity News)
- Is a Goldilocks Solution for Colorectal Cancer Screening Just a Fairy Tale? Overdiagnosis Versus Later Diagnosis of Premalignant Lesions (Gastroenterology)
- Exhaled breath may carry clues to gut microbiome health (Medical Xpress)
- Discovery illuminates how inflammatory bowel disease promotes colorectal cancer (Medical Xpress)
